Navigation Links
CorMedix to Report Third Quarter Financial Results on November 19, 2013
Date:11/15/2013

BRIDGEWATER, N.J., Nov. 15, 2013 /PRNewswire/ -- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardio-renal and infectious disease, today announced that the Company will report financial results for the third quarter ended September 30, 2013 after the close of trading on Tuesday, November 19, 2013.

CorMedix has filed form 12b-25 with the U.S. Securities and Exchange Commission (the "SEC"), and as a result, the deadline for the Company to file its quarterly report on Form 10-Q with the SEC has been extended to November 19, 2013.

CorMedix management will hold a conference call on Wednesday, November 20, 2013, at 9a.m. EST to discuss the results and provide an update on recent business developments.  To access the call, please dial 1-866-866-1333 in the United States, and 1-404-260-1421 internationally.  A live webcast of the conference call will also be available on the investor relations page of the Company's website at www.cormedix.com.

For those unable to participate, a telephonic replay of the call will be available until December 4, 2013.  The replay dial-in numbers are 1-866-430-1300 for domestic callers and 1-404-260-1414 for international callers.  Please use event PIN 4804300 and confirmation number 201311142204363 to access the replay. Additionally, an archived webcast of the event will be available on the CorMedix website for 90 days.

About CorMedix

CorMedix Inc. is a development-stage pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases. CorMedix's most advanced product candidate is Neutrolin®, catheter lock solution for the prevention of catheter related bloodstream infections and maintenance of catheter patency in tunneled, cuffed, central venous catheters used for vascular access in hemodialysis patients. Please see the company's website at www.cormedix.com for additional information.

(Logo: http://photos.prnewswire.com/prnh/20130715/NY47431LOGO )


'/>"/>
SOURCE CorMedix Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CorMedix Inc. Closes $3,000,000 Preferred Stock Offerings
2. CorMedix Reports Receipt of European Patent Office Decision to Allow Prosl Patent to Proceed in European Union
3. CorMedix Reports Second Quarter 2013 Results
4. CorMedix Granted Extension of NYSE MKT Listing
5. ULURU Inc. Reports Third Quarter 2013 Financial Results
6. China Pharma Holdings, Inc. Reports Third Quarter 2013 Financial Results
7. TPI Reports First Quarter Fiscal Year 2014 Financial Results
8. Nephros Reports Third Quarter 2013 Financial Results and Completes Bridge Financing
9. Vermillion Reports Third Quarter 2013 Results
10. Global Radiopharmaceutical Market 2012-2016 Reports
11. SPO Global Reports Results for Third Quarter 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... Ill. and INDIANAPOLIS , ... students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is ... 2016 scholarship winners, announced today online at www.diabetesscholars.org ... let type 1 diabetes stand in the way of ... has supported the Foundation,s scholarship program since 2012, and ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the ... affiliation with Tennessee Counseling Association. This new relationship allows TherapySites to ... Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, ... editors can give their videos a whole new perspective by using the title ... Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to choose ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
Breaking Medicine News(10 mins):